Chen et al. reported that PD-ligand 1 (PD-L1) on exosome surfaces released from metastatic melanoma cells suppressed tumor immunity, and circulating exosomal PD-L1 can be a response predictor of anti-PD-1 therapy [50]. The gene discussed is CD274; the disease is neoplasm.